Paper I
2025 August (Supplementary) (2010 Scheme) · 40 marks · 120 min

Question

Atorvastatin in primary hyperlipidaemia.

Q81 marksShort Answers

Answer

Atorvastatin inhibits HMG-CoA reductase, the rate-limiting enzyme in hepatic cholesterol synthesis. Reduced hepatic cholesterol synthesis triggers compensatory upregulation of hepatic LDL receptors, increasing clearance of LDL particles from the plasma — directly correcting the elevated LDL cholesterol that defines primary hyperlipidemia, and additionally providing a modest reduction in triglycerides and increase in HDL.

Other Years Asked


Revise MBBS
Preview